Fresenius SE

All - 2004

21.12.2004Fresenius Medical Care AG strengthens leading position in emerging European markets
PDF Text as PDF-file
13.12.2004Fresenius Medical Care AG Refinances Senior Credit Facilities
PDF Text as PDF-file
08.12.2004Fresenius Kabi: Market leader builds on success
PDF Text as PDF-file
07.12.2004Fresenius Kabi strengthens position in central and eastern Europe
PDF Text as PDF-file
02.11.2004Fresenius Medical Care reports Third Quarter and Nine Months Results 2004 (for tables see pdf-file)
PDF Text as PDF-file
02.11.20041st-3rd Quarter 2004: Fresenius continues successful revenue and earnings development, raises earnings outlook (for additional tables see pdf-file)
PDF Text as PDF-file
29.10.2004Fresenius ProServe to focus on core activities - Agreement reached on the sale of nursing care business
PDF Text as PDF-file
27.10.2004US subsidiaries of Fresenius Medical Care receive subpoenas
PDF Text as PDF-file
19.10.2004Fresenius announces changes to the Management Board
PDF Text as PDF-file
06.09.2004Fresenius Kabi is expanding its market presence in Australia
PDF Text as PDF-file
04.08.2004Fresenius Medical Care reports Second Quarter and Six Months Results 2004 (for tables see pdf-file)
PDF Text as PDF-file
04.08.2004First Half 2004: Fresenius raises sales and earnings outlook (for tables see pdf-file)
PDF Text as PDF-file
18.05.2004Fresenius Kabi is expanding it's leading market position in South Africa
PDF Text as PDF-file
06.05.2004Fresenius Medical Care reports First Quarter 2004 results; First quarter ahead of expectations
PDF Text as PDF-file
06.05.2004Fresenius announces First Quarter Results 2004 (for tables see pdf-file)
PDF Text as PDF-file
19.03.2004Fresenius receives Orphan Drug Designation for antibody removab® to treat patients with ovarian cancer
PDF Text as PDF-file
17.03.2004Fresenius AG appoints new Member of the Management Board
PDF Text as PDF-file
25.02.2004Fresenius Medical Care AG reports Fourth Quarter and Full Year Results 2003 (for tables see pdf-file)
PDF Text as PDF-file
25.02.2004Fresenius announces results of Financial Year 2003 (for tables see short version in pdf-file)
PDF Text as PDF-file
15.01.2004Capital Market Day Fresenius Biotech: Fresenius concentrates biotechnology activities on antibody and innovative cell therapies
PDF Text as PDF-file
Home  >  Press  >  Press Releases  >  All  >  2004